Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo

被引：56
作者：
Hu, Tao [1 ,2 ,3 ]
Li, Pei [1 ,2 ]
Luo, Zhongguang [4 ]
Chen, Xiaoyu [1 ,2 ]
Zhang, Jingyang [1 ,2 ]
Wang, Chunyao [3 ]
Chen, Ping [1 ,2 ]
Dong, Ziming [1 ,2 ]
机构：
[1] Zhengzhou Univ, Coll Basic Med Sci, Zhengzhou 450001, Henan, Peoples R China
[2] Collaborat Innovat Ctr Henan Prov Canc Chemopreve, Zhengzhou 450001, Henan, Peoples R China
[3] Zhengzhou Univ, Lab Anim Ctr, Zhengzhou 450001, Henan, Peoples R China
[4] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200040, Peoples R China
来源：
ONCOLOGY REPORTS | 2016年 / 35卷 / 01期
关键词：
chloroquine; cell cycle; DNA damage; apoptosis; liver cancer; AUTOPHAGY; APOPTOSIS; DEATH; OXALIPLATIN; ACTIVATION; PROMOTES; SURVIVAL; PATHWAY; SYSTEM; BIM;
D O I：
10.3892/or.2015.4380
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, chloroquine (CQ) has been widely used to improve the efficacy of different chemotherapy drugs to treat tumors. However, the effects of single treatment of CQ on liver cancer have not been investigated. In the present study, we examined the effects of CQ on the growth and viability of liver cancer cells in vitro and in vivo, and revealed that CQ treatment triggered G0/G1 cell cycle arrest, induced DNA damage and apoptosis in a dose- and time-dependent manner in liver cancer cells. Moreover, administration of CQ to tumor-bearing mice suppressed the tumor growth in an orthotopic xenograft model of liver cancer. These findings extend our understanding and suggest that CQ could be repositioned as a treatment option for liver cancer as a single treatment or in combination.
引用
收藏
页码：43 / 49
页数：7
相关论文
共 31 条
  • [1] Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
    Akiyama, Toru
    Dass, Crispin R.
    Choong, Peter F. M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12) : 3173 - 3180
  • [2] Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
    Al-Bari, Md. Abdul Alim
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) : 1608 - 1621
  • [3] Chloroquine Targets Pancreatic Cancer Stem Cells via Inhibition of CXCR4 and Hedgehog Signaling
    Balic, Anamaria
    Draeby Sorensen, Morten
    Maria Trabulo, Sara
    Sainz, Bruno, Jr.
    Cioffi, Michele
    Vieira, Catarina R.
    Miranda-Lorenzo, Irene
    Hidalgo, Manuel
    Kleeff, Joerg
    Erkan, Mert
    Heeschen, Christopher
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (07) : 1758 - 1771
  • [4] Hepatocellular Carcinoma and Chemotherapy: The Role of p53
    Brito, A. F.
    Abrantes, A. M.
    Pinto-Costa, C.
    Gomes, A. R.
    Mamede, A. C.
    Casalta-Lopes, J.
    Goncalves, A. C.
    Sarmento-Ribeiro, A. B.
    Tralhao, J. G.
    Botelho, M. F.
    [J]. CHEMOTHERAPY, 2012, 58 (05) : 381 - 386
  • [5] Oncogenic BRAFV600E inhibits BIM expression to promote melanoma cell survival
    Cartlidge, Robert A.
    Thomas, G. R.
    Cagnol, Sebastien
    Jong, Kimberly A.
    Molton, Sarah A.
    Finch, Andrew J.
    McMahon, Martin
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (05) : 534 - 544
  • [6] Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer
    Chen, Ping
    Hu, Tao
    Liang, Yupei
    Jiang, Yanan
    Pan, Yongfu
    Li, Chunjie
    Zhang, Ping
    Wei, Dongping
    Li, Pei
    Jeong, Lak Shin
    Chu, Yiwei
    Qi, Hui
    Yang, Meng
    Hoffman, Robert M.
    Dong, Ziming
    Jia, Lijun
    [J]. ONCOTARGET, 2015, 6 (11) : 9002 - 9017
  • [7] New uses for old drugs
    Chong, Curtis R.
    Sullivan, David J., Jr.
    [J]. NATURE, 2007, 448 (7154) : 645 - 646
  • [8] Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics
    Cragg, Mark S.
    Kuroda, Junya
    Puthalakath, Hamsa
    Huang, David C. S.
    Strasser, Andreas
    [J]. PLOS MEDICINE, 2007, 4 (10) : 1681 - 1690
  • [9] Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation
    Ding, Zhen-Bin
    Hui, Bo
    Shi, Ying-Hong
    Zhou, Jian
    Peng, Yuan-Fei
    Gu, Cheng-Yu
    Yang, Hua
    Shi, Guo-Ming
    Ke, Ai-Wu
    Wang, Xiao-Ying
    Song, Kang
    Dai, Zhi
    Shen, Ying-Hao
    Fan, Jia
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (19) : 6229 - 6238
  • [10] Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells
    Du, Hailei
    Yang, Weiping
    Chen, Lin
    Shi, Mingming
    Seewoo, Varun
    Wang, Jiayu
    Lin, Andy
    Liu, Zhuoran
    Qiu, Weihua
    [J]. ONCOLOGY REPORTS, 2012, 27 (01) : 143 - 150
1234